Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Effect of Intravitreal Anti-Vascular Endothelial Growth Factors on Retinal Vessels Diameter
Authors not listed
University of Malaya · 2012
Abstract
Patients who will be scheduled for intravitreal injection of Ranibizumab or Bevacizumab will be recruited in this prospective self-controlled trial. Fundus photography will carried out at baseline immediately before injection and at 3, 7 days and 30 days after the first injection. Using image analysis software, measurements summarized as the central retinal artery equivalent (CRAE) and central retinal vein equivalent (CRVE).
Null Hypothesis: There is no significant difference between arteriolar/venular diameter before and after injection of intravitreal ranibizumab/bevacizumab in the treated and untreated eye
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-02 MST
Cite this
APA
Anonymous. (2012). Effect of Intravitreal Anti-Vascular Endothelial Growth Factors on Retinal Vessels Diameter. <em>University of Malaya</em>. https://clinicaltrials.gov/study/NCT01626339
Vancouver
Anonymous. Effect of Intravitreal Anti-Vascular Endothelial Growth Factors on Retinal Vessels Diameter. University of Malaya. 2012.
BibTeX
@misc{anon2012Effect,
title = {Effect of Intravitreal Anti-Vascular Endothelial Growth Factors on Retinal Vessels Diameter},
author = {Anonymous},
journal = {University of Malaya},
year = {2012},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Prof. Dr. Med. Laimonas Griskevicius 2011
Open access · US-GOV
Study of Rituximab in Addition to Glucocorticoid in Pretreated Elderly or Unfit Patients With Chronic B Lymphocytic Leukemia
Assiut University 2026
Open access · US-GOV
Monitoring Changes in Intraocular Pressure After Intravitreal Injection
Sheba Medical Center 2007
Open access · US-GOV
The Effect of Intravitreal Avastin on the Retina Measured by Electroretinogram
Vastra Gotaland Region 2020
Open access · US-GOV
The Sahlgrenska Anti-VEGF (SAHLVE) Study - a Prospective Randomized Double-blind Comparison of Bevacizumab and Aflibercept in Patients With Neovascular Age-related Macular Degeneration
Unity Health Toronto 2017
Open access · US-GOV
Cytokine and Visual Outcome Variations in Eyes Receiving a Variable Dosing Aflibercept Treatment: The COVARIANT Study
University of Novi Sad 2021
Open access · US-GOV